85 related articles for article (PubMed ID: 12218879)
1. Economic and social effects of high-dose buprenorphine substitution therapy. Six-month results.
Lavignasse P; Lowenstein W; Batel P; Constant MV; Jourdain JJ; Kopp P; Reynaud-Maurupt C; Riff B; Videau B; Mucchielli A
Ann Med Interne (Paris); 2002 May; 153(3 Suppl):1S20-6. PubMed ID: 12218879
[TBL] [Abstract][Full Text] [Related]
2. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
[TBL] [Abstract][Full Text] [Related]
3. Comparison of high dose buprenorphine treatments of opiate dependent outpatients in four healthcare networks.
De Ducla M; Gagnon A; Mucchielli A; Robinet S; Vellay A
Ann Med Interne (Paris); 2000 Oct; 151 Suppl B():B9-15. PubMed ID: 11104938
[TBL] [Abstract][Full Text] [Related]
4. Comparison of costs and utilization among buprenorphine and methadone patients.
Barnett PG
Addiction; 2009 Jun; 104(6):982-92. PubMed ID: 19466922
[TBL] [Abstract][Full Text] [Related]
5. A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal.
Doran CM; Shanahan M; Bell J; Gibson A
Drug Alcohol Rev; 2004 Jun; 23(2):171-5. PubMed ID: 15370023
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic response in outpatient opioid substitution treatment].
Barisić V; Barisić Z
Acta Med Croatica; 2009 Oct; 63(4):279-83. PubMed ID: 20034328
[TBL] [Abstract][Full Text] [Related]
7. Exposure to opioid maintenance treatment reduces long-term mortality.
Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
[TBL] [Abstract][Full Text] [Related]
8. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
[TBL] [Abstract][Full Text] [Related]
9. The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia.
Winstock AR; Lea T; Ritter A
Drug Alcohol Rev; 2007 Jul; 26(4):411-6. PubMed ID: 17564877
[TBL] [Abstract][Full Text] [Related]
10. Induction of patients with moderately severe methadone dependence onto buprenorphine.
Glasper A; Reed LJ; de Wet CJ; Gossop M; Bearn J
Addict Biol; 2005 Jun; 10(2):149-55. PubMed ID: 16191667
[TBL] [Abstract][Full Text] [Related]
11. Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: results of a multicenter study of 73 patients.
Poirier MF; Laqueille X; Jalfre V; Willard D; Bourdel MC; Fermanian J; Olié JP
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):267-72. PubMed ID: 14751421
[TBL] [Abstract][Full Text] [Related]
12. A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial.
Raistrick D; West D; Finnegan O; Thistlethwaite G; Brearley R; Banbery J
Addiction; 2005 Dec; 100(12):1860-7. PubMed ID: 16367987
[TBL] [Abstract][Full Text] [Related]
13. [Follow-up of opioid addicts treated with high-dose buprenorphine in a health care network. National retrospective study. Experience of French general physicians].
De Ducla M; Gagnon A; Mucchielli A; Robinet S; Vellay A
Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A27-32. PubMed ID: 10855374
[TBL] [Abstract][Full Text] [Related]
14. Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.
Reece AS
J Subst Abuse Treat; 2009 Oct; 37(3):256-65. PubMed ID: 19394789
[TBL] [Abstract][Full Text] [Related]
15. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
16. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
[TBL] [Abstract][Full Text] [Related]
17. The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001-03.
de Wet CJ; Reed LJ; Bearn J
Addiction; 2005 Apr; 100(4):495-9. PubMed ID: 15784064
[TBL] [Abstract][Full Text] [Related]
18. Favorable mortality profile of naltrexone implants for opiate addiction.
Reece AS
J Addict Dis; 2010 Jan; 29(1):30-50. PubMed ID: 20390697
[TBL] [Abstract][Full Text] [Related]
19. [Predictive factors for patient maintenance on buprenorphine high dosage treatment: a naturalistic study in primary care].
Gasquet I; Lançon C; Parquet P
Encephale; 1999; 25(6):645-51. PubMed ID: 10668610
[TBL] [Abstract][Full Text] [Related]
20. [Maintenance treatment with high-dose buprenorphine: are the recommendations being followed?].
Seyer D; Dif C; Balthazard G; Sciortino V
Therapie; 1998; 53(4):349-54. PubMed ID: 9806004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
